40+ years’ experience of the European pharmaceutical industry in general and 35 years in generics in particular gives Interpharm the background to help you with whatever generic or biosimilar issues you may be facing.
Areas of Expertise
Whether you are thinking about:
Generic Business Development
Market intelligence and pricing data for generics and biosimilars
Introducing your generic products into Europe or Israel
Generic product out-licensing in Europe, Israel or the United States
Planning some internal training (webinars, on-site or podcasts)
Finding new products to extend your range
How to devise an effective defence strategy to protect your brands against generic competition
Entering into the biosimilars market
Bioequivalence studies for your generic developments
Interpharm can also help with in-house training and podcasts that are tailored to your company’s individual needs on topics such as understanding the generic and biosimilar markets and the legal and IP issues that affect them. To find out more about training and symposia and previous speaking engagements please see the Curriculum Vitae page.
A little bit of history…..
Interpharm Consultancy has been assisting companies in the generic pharmaceutical industry since 1997.
With a background of over 35 years in generics, I specialise in:-
competitive generics and biosimilars intelligence
advising on growth strategies or market entry strategies
helping with business development
training for new employees on understanding the generic marketplace, IP background and regulatory issues
locating products and registration dossiers for EU companies
providing a link between firms in the EU and companies based overseas who are trying to gain entry into this very competitive marketplace
assisting branded companies to plan their defence strategies against generics
offering help to companies looking for generic acquisitions
Please follow the link for some examples of previous projects
Interpharm has worked with a number of companies on a variety of generic-related projects. A few examples of these assignments appear on the Services page.
If you want to know about generic pharmaceuticals and biosimilars -please contact us to see how we can help
Thank you for your interest in Interpharm Consultancy.
PLEASE NOTE:
Interpharm will be closing on 31st December 2024 due to the retirement of Peter Wittnerwho will no longer be available to assist you with your plans.